Keywords:
Retinopathy of prematurity; early detection; screening; oxygen therapy; prevention; premature infants.References
Blencowe H., Lawn J.E., Vazquez T., Fielder A., Gilbert C. Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010. Pediatric Research. 2020;87(Suppl 1):37–44.
Campbell K., Vinekar A., Gilbert C. Global causes of childhood blindness and visual impairment: Retinopathy of prematurity in the 21st century. Ophthalmology. 2021;128(5):653–655.
Chen J., Smith L.E.H. Retinopathy of prematurity: Pathogenesis and prevention. Seminars in Perinatology. 2019;43(6):101–109.
Fierson W.M. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2020;145(1):e20193936.
Gilbert C., Foster A. Childhood blindness in the context of VISION 2020—The right to sight. Bulletin of the World Health Organization. 2019;97(10):689–690.
Hellström A., Smith L.E.H., Dammann O. Retinopathy of prematurity. The Lancet. 2018;392(10165):1445–1457.
Lyu Y., Shah P.S., Ye X.Y. Association between oxygen saturation targeting and severe retinopathy of prematurity. JAMA Pediatrics. 2020;174(8):1–9.
Mintz-Hittner H.A., Kennedy K.A., Chuang A.Z. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. New England Journal of Medicine. 2019;364(7):603–615.
Quinn G.E., Ying G.S., Daniel E. Timing of detection of retinopathy of prematurity and related outcomes. Ophthalmology. 2021;128(3):403–411.
Wong K., Thompson L., Young D.L. Telemedicine approaches for retinopathy of prematurity screening: A systematic review. British Journal of Ophthalmology. 2022;106(4):475–482.